CACMLE Hemostasis Courses

212-Online: Acquired Thrombotic Risk Factors – Section 2 of “Hereditary and Acquired Thrombotic Risk Factors”


Contact Hours (Points): 3

This course presents a detailed discussion of the currently recognized Hereditary and acquired risk factors for thrombotic disease. A basic review of the biochemical pathway of coagulation and a brief discussion of the vascular phase of hemostasis are provided to orientate the reader to the sites of action of the various risk factors. This introductory section is followed by an in-depth discussion of each of the risk factors with emphasis on methods of diagnosis and treatment. Case histories are provided for each risk factor to illustrate the methods of diagnosis and types of treatment discussed in the test. The exam to this course is unchanged.

Buy This Course At Our Store Site

Product Description

Acquired Thrombotic Risk Factors – Section 2 of “Hereditary and Acquired Thrombotic Risk Factors”

Self-Study 212 – Intermediate Level

Contact Hours (Points): 3

Written by Michael J. Sanfelippo MS, MT(ASCP)

Reviewed 2015. Updated 2013 (Exam is unchanged). Published 2002.

Online – 212: Course Taken Online: $36.00 BUY NOW

IMPORTANT: This online course is accessible using the following:

Desktop or Laptop Computer – Download the latest Adobe Reader program.

Kindle Fire – No additional App download is necessary.

Apple iPad (all versions) / Nook / Kindle – Recommend purchase of a PDF Reader App, such as GoodReader, Cloudreaders, or Stanza by Amazon. Once downloaded, launch this App to access the course online site in order to logon to and view your course.

Coagulation; Regulation of Coagulation; Vascular Phase of Hemostasis
The Antiphospholipid Syndrome / Lupus Anticoagulant; Historical Perspective; Mechanism of Thrombosis in the Antiphospholipid Syndrome and Lupus Anticoagulant; Diagnostic Criteria for the Antiphospholipid Syndrome and the Lupus Anticoagulant; The Lupus Anticoagulant; Laboratory Testing; Clinical Manifestation of the Antiphospholipid Syndrome; Treatment of the Antiphospholipid Syndrome; Case Histories for the Antiphospholipid Syndrome;
Case #1; Case #2; Case #3; Catastrophic Antiphospholipid Syndrome; Case study; Thrombosis Associated with Malignancy; Mechanisms of Thrombosis in Patients with Malignancies; Clinical Presentation of Thrombosis in Patients with Malignancy; Laboratory Testing; Treatment of Thrombosis in Patients with Malignancies; Case Histories; Case #1; Case #2; Thrombosis Associated with the Nephrotic Syndrome; Mechanisms of Thrombosis in the Nephrotic Syndrome; Laboratory Identification of Thrombotic Risk in Nephrotic Syndrome and Treatment; Case History; Heparin-Induced Thrombocytopenia (HIT); Mechanism; Clinical Manifestation; Laboratory Identification of HIT Antibody; Case History; Warfarin-Induced Tissue Necrosis; Case History; Pregnancy as a Thrombotic Risk Factor; Mechanism; Treatment; Case History; Oral Contraceptive Therapy as a Risk Factor for Thrombosis; Mechanism; Precautions; Case History

Share this!